Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders

February 03, 2021

Senescent cells accumulate in organs during aging, promote tissue dysfunction, and cause numerous aging-related diseases like cancer. The cells arise through a process called "cellular senescence," a permanent cell cycle arrest resulting from multiple stresses.

A collaborative research group led by Professor Makoto Nakanishi of the Institute of Medical Science, The University of Tokyo (IMSUT), and co-researchers has identified an inhibitor of the glutamate metabolic enzyme GLS1(*1) so that its administration selectively eliminates senescent cells in vivo. They confirmed that the GLS1 inhibitor eliminated senescent cells from various organs and tissues in aged mice, ameliorating age-associated tissue dysfunction and the symptoms of obese diabetes, arteriosclerosis, and NASH. The results of this research were published in "Science" on January 15, 2021.

Previous studies have shown that genetically engineering removal of senescent cells from aged mice delays the onset of geriatric diseases such as arteriosclerosis and renal damage and extends the healthy life expectancy. However, those studies have not led to identifying useful drug candidates.

Professor Nakanishi said," Our results can contribute to the development of new anti-aging therapies that remove senescent cells by targeting these cells' metabolic characteristics.".

Lysosomal membranes hold the key to senescent cell removal

The research team has developed a new method for producing purified senescent cells to search for genes essential for senescent cells' survival. This new method activates the p53 gene in the G2 phase, which can efficiently induce cellular senescence.

They used purified senescent cells to search for genes essential for senescent cells' survival, then identified GLS1, which is involved in glutamine metabolism, as a potential candidate gene.

When they examined the effect of GLS1 inhibitor on the mortality of senescent cells, senescent cells were more sensitive to GLS1 inhibition due to damage to the lysosomal membrane and decreased intracellular pH. When they administered GLS1 inhibitors to aged mice, senescent cells in various tissues and organs were removed, and the aging phenomenon was significantly improved.

Organelles called lysosomes(*2) play an essential role in the regulation of intracellular pH. The team analyzed the dynamics of lysosomes and found the vital fact that damage to the lysosomal membranes in senescent cells lowers intracellular pH.

For details of the research, please see the paper.

Expectations for innovative anti-aging therapies and treatments for geriatric diseases

The results of this study show more interesting results. As aging progresses, motor function declines due to muscle loss, and metabolic disorders due to adipose tissue atrophy occur. But, when the research team injected GLS1 inhibitors into mice suffering age-related disorders, the progression of these age-related symptoms was suppressed. Moreover, GLS1 inhibitors were able to relieve the symptoms of obese diabetes, arteriosclerosis, and NASH(*3).

According to the team, GLS1 inhibitors are currently in clinical trials as effective cancer treatments. "We hope that innovative anti-aging therapies and treatments for geriatric diseases will be developed that can remove senescent cells by treatment with GLS1 inhibitors," said Professor Nakanishi.
-end-
Co-researches

Keiichi Nakayama (Professor, Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University)

Masaki Matsumoto (Professor?Department of Omics and Systems Biology?Niigata University)

Makoto Suematsu (Professor, Department of Biochemistry, Keio University School of Medicine)

Yuki Sugiura (Assistant Professor, Department of Biochemistry, Keio University School of Medicine)

Makoto Arita (Team leader, Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences)

Masataka Sugimoto (Director, Research Institute, National Center for Geriatrics and Gerontology)

Research Notes

(*1) GLS1

Abbreviation for glutaminase 1. A type of amidohydrolase enzyme that produces glutamic acid and ammonia from glutamine.

(*2) Lysosomes

One of the membrane-enclosed organelles of eukaryotes. The lumen of lysosomes is acidified to around pH 5 and contains hydrolases, allowing the organelle to perform intracellular digestion.

(*3) NASH

A disease in which fat accumulates in the liver in an alcohol-independent manner, causing inflammation and fibrosis. As it progresses, it causes cirrhosis and liver cancer.

The Institute of Medical Science, The University of Tokyo

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.